IQV
What one share of Iqvia Holdings holds
Services – Commercial Physical and Biological Research
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI®, advanced analytics, the latest technologies and extensive domain expertise.
Iqvia Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-03-31; the balance sheet is as of 2026-03-31.
| Sales | $96.92 |
|---|---|
| Profit | $8.07 |
| Capex (buildings and equipment) | $3.43 |
| Free cash flow | $12.33 |
| Cash and investments | $12.60 |
| Debt | $94.87 |
| Book value | $37.27 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $45.25 | $0.47 | $1.08 | $4.58 | — | $34.77 |
| 2017 | $43.75 | $5.74 | $1.66 | $2.70 | — | $38.39 |
| 2018 | $50.01 | $1.24 | $2.20 | $3.82 | — | $33.99 |
| 2019 | $55.55 | $0.96 | $2.92 | $4.18 | — | $31.22 |
| 2020 | $58.25 | $1.43 | $3.16 | $6.89 | — | $31.39 |
| 2021 | $71.15 | $4.95 | $3.28 | $11.81 | — | $31.70 |
| 2022 | $75.60 | $5.72 | $3.54 | $8.32 | — | $31.04 |
| 2023 | $80.43 | $7.29 | $3.48 | $8.05 | — | $33.67 |
| 2024 | $84.00 | $7.49 | $3.28 | $11.53 | — | $34.45 |
| 2025 | $94.01 | $7.84 | $3.48 | $11.82 | — | $38.34 |